Your browser doesn't support javascript.
loading
Clinical Outcomes of S-1 Monotherapy and Modified FOLFIRINOX Therapy after Gemcitabine plus Nab-paclitaxel Therapy in Unresectable Pancreatic Cancer.
Hino, Kaori; Nishina, Tomohiro; Numata, Yuuki; Asagi, Akinori; Inoue, Tomonori; Yoshimatsu, Megumi; Sakaguchi, Chihiro; Nakasya, Akio; Nishide, Norifumi; Kajiwara, Takeshi; Terao, Takashi; Nadano, Seijin; Marui, Kaori; Okujima, Yusuke; Kokubu, Masahito; Imamura, Yoshiki; Kanemitsu, Kozue; Koizumi, Mitsuhito; Kumagi, Teru; Hiasa, Yoichi; Hyodo, Ichinosuke.
Afiliação
  • Hino K; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Japan.
  • Nishina T; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Japan.
  • Numata Y; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Japan.
  • Asagi A; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Japan.
  • Inoue T; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Japan.
  • Yoshimatsu M; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Japan.
  • Sakaguchi C; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Japan.
  • Nakasya A; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Japan.
  • Nishide N; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Japan.
  • Kajiwara T; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Japan.
  • Terao T; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Japan.
  • Nadano S; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Japan.
  • Marui K; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Japan.
  • Okujima Y; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Japan.
  • Kokubu M; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Japan.
  • Imamura Y; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Japan.
  • Kanemitsu K; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Japan.
  • Koizumi M; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Japan.
  • Kumagi T; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Japan.
  • Hiasa Y; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Japan.
  • Hyodo I; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Japan.
Intern Med ; 61(15): 2255-2261, 2022.
Article em En | MEDLINE | ID: mdl-35908959
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article